Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Trillium Health Care Products operates as a leading North American CDMO specializing in the formulation and manufacturing of prescription and over-the-counter pharmaceuticals. The company has over five decades of experience producing a wide range of dosage forms under GMP conditions for major pharma and consumer healthcare brands. It was acquired by Avista Healthcare Partners in August 2024.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Trillium Health Care Products.